Nottingham Osteoarthritis Biomarker Study 2011

Completed

You are on the General Public view
  • Source

    -
    Public Title Nottingham Osteoarthritis Biomarker Study 2011
    Acronym Sorry, not currently available
    Source of Record URL http://clinicaltrials.gov/show/NCT01495455
  • Trial

    -
    Health Condition(s) or Problem Osteoarthritis
    Lay Summary Osteoarthritis is by far the most common joint condition and the single largest cause of disability in the older population. The investigators still have a poor understanding of the nature of osteoarthritis and factors that influence its development and progression. Identification of biochemical markers that relate to cartilage loss, bony overgrowth and other features that occur with osteoarthritis will advance our understanding. Over the last 5 years analytical methods have developed to measure a range of different biomarkers. This pilot study will use these analytical methods to measure biomarker levels in joint fluid, urine and blood of 50 participants with Osteoarthritis (OA) and 50 healthy volunteers. This study will provide novel pilot data on the changes in the composition of the synovial fluid, urine and blood in patients with OA. Apart from being a key target site for OA, the knee is a suitable joint for study because of its accessibility to clinical assessment, joint aspiration and imaging. (from ClinicalTrials.gov)
    Who can enter the trial Inclusion Criteria: All participants: - Be able to provide written informed consent - Aged 30 and over Knee OA patients: • Radiographic signs of OA - that is definite joint space narrowing plus osteophyte in at least one compartment of the knee Normal controls: - No knee pain - No clinical or radiographic changes of knee OA
    Who cannot enter the trial Inclusion Criteria: All participants: - Be able to provide written informed consent - Aged 30 and over Knee OA patients: • Radiographic signs of OA - that is definite joint space narrowing plus osteophyte in at least one compartment of the knee Normal controls: - No knee pain - No clinical or radiographic changes of knee OA
    What will happen Sorry, not currently available
    Primary aim Difference in the levels of pro-inflammatory and anti-inflammatory lipids mediators between individuals with knee osteoarthritis and those with normal knees.
    Secondary Aim Sorry, not currently available
    Participant Information Sheet Sorry, not currently available
    Website Sorry, not currently available
    Recruitment Status Completed
    Nation England
    Location Nottingham
  • Contact

    -
    Contact for Public Queries Michael Doherty, MA MB FRCP Principal Investigator University of Nottingham
    Contact for Scientific Queries Sorry, not currently available
Please note:
  1. The UKCTG information is designed to inform you of existing trials. If you wish to join a specific trial, you must discuss this with your own doctor who may decide to get in touch with the contact listed.
  2. The UKCTG is not responsible for the quality of the data displayed in the Gateway but can contact the data providers. Please contact us if you have any query regarding the quality of trial records.